CorMedix Inc. (CRMD)
CRMD Stock Price Chart
Explore CorMedix Inc. interactive price chart. Choose custom timeframes to analyze CRMD price movements and trends.
CRMD Company Profile
Discover essential business fundamentals and corporate details for CorMedix Inc. (CRMD) to support your stock research and investment decisions.
Sector
Healthcare
Industry
Biotechnology
IPO Date
13 May 2010
Employees
64.00
Website
https://www.cormedix.comCEO
Joseph Todisco MBA
Description
CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases in the United States and internationally. Its lead product candidate is DefenCath/Neutrolin, a novel anti-infective solution for the reduction and prevention of catheter-related infections and thrombosis in patients requiring central venous catheters in clinical settings, such as hemodialysis, total parenteral nutrition, and oncology. The company was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. CorMedix Inc. was incorporated in 2006 and is based in Berkeley Heights, New Jersey.
CRMD Financial Timeline
Browse a chronological timeline of CorMedix Inc. corporate events including earnings releases, dividend announcements, and stock splits.
Upcoming earnings on 4 May 2026
Upcoming earnings on 29 Oct 2025
EPS estimate is $0.37, while revenue estimate is $63.27M.
Earnings released on 7 Aug 2025
EPS came in at $0.28 surpassing the estimated $0.20 by +40.00%, while revenue for the quarter reached $39.74M , missing expectations by -6.41%.
Earnings released on 6 May 2025
EPS came in at $0.30 surpassing the estimated $0.25 by +20.00%, while revenue for the quarter reached $39.08M , beating expectations by +30.80%.
Earnings released on 25 Mar 2025
EPS came in at $0.22 surpassing the estimated $0.17 by +29.41%, while revenue for the quarter reached $31.21M , missing expectations by -0.19%.
Earnings released on 30 Oct 2024
EPS came in at -$0.05 surpassing the estimated -$0.10 by +50.00%, while revenue for the quarter reached $11.46M , missing expectations by -42.11%.
Earnings released on 14 Aug 2024
EPS came in at -$0.25 surpassing the estimated -$0.26 by +3.85%, while revenue for the quarter reached $806.12K , missing expectations by -51.73%.
Earnings released on 9 May 2024
EPS came in at -$0.25 surpassing the estimated -$0.27 by +7.41%.
Earnings released on 12 Mar 2024
EPS came in at -$0.26 falling short of the estimated -$0.21 by -23.81%, while revenue for the quarter reached $304.11K , beating expectations by +221.64%.
Earnings released on 14 Nov 2023
EPS came in at -$0.17 surpassing the estimated -$0.21 by +19.05%.
Earnings released on 8 Aug 2023
EPS came in at -$0.25 falling short of the estimated -$0.22 by -13.64%.
Earnings released on 15 May 2023
EPS came in at -$0.24 falling short of the estimated -$0.20 by -20.00%.
Earnings released on 30 Mar 2023
EPS came in at -$0.20 falling short of the estimated -$0.19 by -5.26%, while revenue for the quarter reached $29.70K , beating expectations by +1.17K%.
Earnings released on 10 Nov 2022
EPS came in at -$0.17 surpassing the estimated -$0.23 by +26.09%, while revenue for the quarter reached $6.82K .
Earnings released on 11 Aug 2022
EPS came in at -$0.19 surpassing the estimated -$0.20 by +5.00%, while revenue for the quarter reached $21.25K .
Earnings released on 12 May 2022
EPS came in at -$0.18 surpassing the estimated -$0.23 by +21.74%, while revenue for the quarter reached $7.64K , missing expectations by -69.46%.
Earnings released on 29 Mar 2022
EPS came in at -$0.20 surpassing the estimated -$0.22 by +9.09%, while revenue for the quarter reached $56.40K , beating expectations by +196.83%.
Earnings released on 9 Nov 2021
EPS came in at -$0.22 falling short of the estimated -$0.18 by -22.22%, while revenue for the quarter reached $38.09K , beating expectations by +90.44%.
Earnings released on 12 Aug 2021
EPS came in at -$0.12 surpassing the estimated -$0.18 by +33.33%, while revenue for the quarter reached $8.19K , missing expectations by -79.52%.
Earnings released on 13 May 2021
EPS came in at -$0.20 falling short of the estimated -$0.18 by -11.11%, while revenue for the quarter reached $88.26K , beating expectations by +2.98K%.
Earnings released on 30 Mar 2021
EPS came in at -$0.19 surpassing the estimated -$0.23 by +17.39%, while revenue for the quarter reached $55.71K .
Earnings released on 5 Nov 2020
EPS came in at -$0.22 surpassing the estimated -$0.26 by +15.38%, while revenue for the quarter reached $93.02K .
CRMD Stock Performance
Access detailed CRMD performance analysis with candlestick charts, real‑time intraday data and historical financial metrics for comprehensive insights.
Explore Related Stocks
Compare companies within the same sector by viewing performance, key financials, and market trends. Select a symbol to access the full profile.